Community
Public Outreach

Public Outreach

EAACI seeks to tackle the burden of allergy in Europe with evidence-based recommendations and by joining forces with relevant European actors in the field. The European Parliament Interest Group on Allergy and Asthma is a policy forum to share expertise and align interests engaging with EU policy-makers and stakeholders on allergy and asthma health. Learn more about the Interest Group’s upcoming and past activities, in addition to a variety of public outreach initiatives here.

Filter

What are you looking for?

Category
- adolescent
- aerobiology and pollution
- allergen immunotherapy (AIT)
- AllergoOncology
- allergy asthma and a sport
- allergy diagnosis
- allied health and primary care
- anaphylaxis
- angioedema
- artificial intelligence (AI)
- asthma
- basic immunology
- biologicals
- comparative veterinary allergology
- consensus document
- COVID-19
- dermatology
- drug allergy
- EAACI position paper
- EAACI Task Force report
- ENT
- environmental allergy and climate change
- eosinophilic esophagitis (EoE)
- epidemiology
- epithelial cell biology
- exposome
- food allergy
- food allergy and anaphylaxis
- genomics and proteomics
- hypersensitivity
- immune deficiencies and autoimmunity
- immunomodulation and nutrition
- infections
- insect venom hypersensitivities
- mastocytosis and mast cells
- microbiome
- nasal polyposis
- occupational allergy
- ocular allergy
- OMIC technologies in allergy research
- One Health
- pediatrics
- prevention
- systems medicine
- T2 diseases
- transitional
Year
- 2013
- 2014
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abbott Laboratories
- Abdominal pain
- ABPA
- ACE2
- Acoustic rhinometry
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- adolesent and young adult (AYA)
- Adrenaline
- Adrenaline auto-injector
- adult
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- aerosolization
- AGREE II
- Aimmune Therapeutics
- Air pollutant
- Air pollution
- Airborne enzyme
- airways
- AIT
- Algorithm
- ALK
- allegen immunotherapy (AIT)
- allergen
- allergen exposure challenge
- allergen exposure chamber
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- allergen symphony
- Allergen-free foods
- Allergens and epitopes
- allergens and epitopes
- allergic asthma
- allergic bronchopulmonary aspergillosis
- allergic conjunctivitis
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergies to cats
- allergoid-mannan conjugates
- AllergoOncology WG
- Allergopharma
- allergy
- allergy diagnosis
- Allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy immunotherapy
- allergy management
- Allergy risk
- allergy test
- allergy therapeutics
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- alpha-gal allergy
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- anti-epileptic drugs
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- antigen presenting cells
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma care
- asthma control
- asthma exacerbations
- asthma inflammatory
- asthma management
- asthma risk
- Asthma treatment
- Asthma treatment
- asthmatic patients
- Astrazeneca
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- atopy
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- B regulatory cells
- bacterial lysate
- bacterial lysates
- bacterial mucosal immunotherapy
- bacterial products
- Barrier
- Basic and Clinical Immunology Section
- Basic immunology
- basic mechanisms
- Basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- berotralstat
- Bet v 1
- beta-lactam
- beta-lactoglobulin
- Big data
- bigdata
- BioCryst
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- blood eosinophil
- BluePrint Medicines
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- bronchial thermoplasty
- bronchiectasis
- Bronchiolitis
- Bronchoconstriction
- BTK
- c-kit
- C1 inhibitor
- C1-INH
- cabbage
- cancer
- cannabis allergy
- case study
- cats
- causality
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- Childhood allergies
- childhood asthma
- childhoodvaccination
- children
- china
- chlorhexidine
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic rhinosinusitis with nasal polyps (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- classification
- climate
- climate change
- Clinical aspects
- clinical cases
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical tolerance
- clinical trials
- clinicalimmunology
- Cluster analysis
- CMA
- Collegen-binding receptor
- common cold
- companion animals and pets
- Company Sponsored Symposia
- complex world of allergy
- compliance
- component resolved diagnosis
- Component resolved diagnosis (CRD)
- component-resolved diagnosis (CRD)
- Conjunctiva
- conjunctivitis
- Consensus
- consensus document
- contact allergen
- contact dermatitis
- Contact urticaria
- containment
- contraindications
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 pandemic
- COVID-19 vaccine
- COVID-19 vaccines
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactivity
- CRSwNP
- CSL Behring
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Danone/Nutricia
- dbv technologies
- dbv712
- Deep learning
- delabelling
- DELPHI
- Dendritic cells
- dermatologic diseases
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- dietary management
- Differential diagnosis
- digital anamorphosis
- disease (CRD)
- disease burden
- disease control
- disease model
- disease transmission
- disinfection by-products
- disruptive IgE antibody
- DNase
- Drug allergy
- drug allergy
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2021
- eaaci hybrid congress 2022
- eaaci2021
- early diet
- ECDA
- ecosystem
- eczema
- Education
- EETosis
- efficacy
- Egg allergy
- EGR-1
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environment and Immunology StandUp Talks
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- eosinophil
- eosinophilic diseases
- eosinophilic fasciitis
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- epigenetic
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- Esophagitis
- EU
- European parliament
- evidence-based
- exacerbations
- exercise
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- exposome
- faam-eurobat digital 2020
- Faes Farma
- fermentedvegetable
- fiber
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food additives
- food allergy
- Food allergy
- Food aversion
- food labelling
- Food processing
- food protein induced enterocolitis syndrome (FPIES)
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- fungus
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- Global air quality
- global atlas
- glycans
- GRADE
- Grant application
- GSK
- guidelines
- gut microbiome
- Gut microbiota
- HAE
- HAL Allergy
- healthier environment
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- hives
- HMO
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- ICD-11
- IgE
- IL-37b
- imaging
- Immune amnesia
- Immune deficiencies
- Immune health
- immune phenotype
- immune response
- immune system
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- immunology
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immune training
- Innate immunity
- innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- Insect Venom Allergy
- insects
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international classification of diseases (ICD)
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- itch
- Kawasakisyndrome
- kimchi
- Lactobacillus
- lanadelumab
- learning methods
- LETI Pharma
- ligelizumab
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- mast cell
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- Medthority CME supported by Novartis
- memory B cells
- Menarini Group
- mental health
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- methods
- mHealth
- Microbial Disease
- microbial products
- Microbiome
- microbiota
- MicroCrystalline
- micronutrient
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- monocytes
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- Multiple myeloma
- multisystem allergy
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- nasal allergen challenge
- nasal endoscopy
- nasal polyposis
- nasal polyps…)
- neonates
- Nestlé Health Science
- Nestlé Nutrition Institute
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- New challenges
- newborns
- Next generation
- NLR
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- noninvasive diagnosis
- Noucor
- Novartis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- older (adults/people)
- older adults
- Olfactory disturbance
- Olink
- OM Pharma
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral challenge
- oral food challenge
- Oral immunotherapy
- outbreak
- Outcome measures
- PAAAM 2021
- PAAM 2021
- PAAM Digital 2021
- paediatric awareness
- Paediatrics
- PAF
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient care
- patient reported outcome
- peak expiratory flow
- peak expiratory flow (PEF)
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatric asthma
- pediatric atopic dermatitis
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- personalized medicine
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Pharming
- Phase-3 study
- Phenotype
- phenotypes
- physiology
- Pine nut allergy
- PIPEline
- Placebo effect
- placebo effects
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollutants
- pollution
- polyethilen glycol
- polyethylene glycol
- PRACTALL
- prebiotics
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- Prevention
- primary care
- primary immunodeficiency
- Probiotic
- probiotics
- proctocolitis
- Prophylactic Treatment
- proresolvinglipids
- protection
- protectiveantibodies
- protein contact dermatitis
- proteomics
- Proteotomics
- Proton pump inhibitor
- pruritus
- Psoriasis
- psychological effects
- psychology
- pulmonary rehabilitation
- Purina Institute
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- Regulatory aspects
- regulatory authorities
- Relegating OCS to last resort: Creating a paradigm shift in asthma management
- Remodelling
- reslizumab
- respiratory allergies
- respiratory allergy
- Respiratory infections
- Revenio
- Rhinitis
- Rhinitis Monitoring
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- rupatadine
- safety
- SAM 2021
- SAM2021
- SANI
- Sanofi Regeneron
- SARC-CoV-2
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- scientific career
- scoring system
- self‐management
- sensitization
- sensitization profile
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- severe cutaneous adverse drug reactons
- severe eisinophilic asthma
- severe type 2 asthma
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- sinusitis
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- smell
- SoMe
- Spirometry
- sport
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- StandUp Talks
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- survey
- Symptom scale
- Symptom score
- synbiotics
- system biology
- systematic mastocytosis
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Takeda
- TAKHZYRO
- Tcells
- technical standards
- teenager
- tele-health
- teleHealth
- telemedicine
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- therapies
- Thermo Fisher Scientific
- threshold dose
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- tree nut allergy
- Tree-nut allergy
- Trichinella spiralis
- Tryptase
- TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
- type 2 inflammation
- UCARE
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria in children
- urticarial vasculitis
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheal
- wheezing child
- white paper
- World Health Organization (WHO)
- WS 2023 Davos
- Xlinkedagammaglobulinemia
- yellow fever
- young adult
- young adults
- young children
Author
- Aberer, W.
- Achten, R.
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Altrichter, S.
- Alvarez-Cuesta, E.
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Annesi-Maesano, I.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Ardern-Jones, M.R.
- Arkhipova, S.
- Arnold, A.
- Arrais, M.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Aygören-Pürsün, E.
- Bacharier, L.
- Bachert, C.
- Baerenfaller, K.
- Bansal, P.
- Barbaud, A.
- Barber, D.
- Bartel, S.
- Bartra, J.
- Baumann, R.
- Bavbek, S.
- Bazan-Socha, S.
- Beausoleil, J.
- Beck, E.
- Beck, L.
- Bégin, P.
- Beken, B.
- Benito Villalvilla, C.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Betschel, S.
- Beyer, K.
- Bianchini, R.
- Biedermann, T.
- Birrell, F.
- Bisyuk, Y.
- Blain, H.
- Blanca-Lopez, N.
- Blasi, F.
- Blümchen, K.
- Boccabella, C.
- Boguniewciz, M.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Borres, M.
- Bosco, A.
- Bosnic-Anticevich, S.
- Bossios, A.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A.
- Bozkurt, B.
- Braido, F.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Bredenoord, A.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Brusselle, G.
- Burks, W.
- Busse, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calado, R.
- Calder, V.
- Calderon, M.
- Calvão, J.
- Camargo Lopes de Oliveira, L.
- Campbell, D.
- Canonica, G.W.
- Cardona, V.
- Carnés, J.
- Carter, M.
- Casale, T.
- Castells, M.
- Castillejo, G.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Chaker, A.
- Chan, E.
- Chandra, A.
- Chawes, B.
- Chehade, M.
- Chivato, T.
- Cho, Y.
- Chung, K.
- Cianferoni, A.
- Cimbollek, S.
- Clark, A.
- Clark, E.
- Cogo, A.
- Cojanu, C.
- Comberiati, P.
- Constantinides, M.
- Corbett, M.
- Cornejo-Garcia, J.A.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- Dávila, I.
- de Blay, F.
- De Craemer, J.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P.
- Descamps, V.
- Deschildre, A.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dörr, T.
- Dramburg, S.
- Drijver-Messelink, M.T.
- du Toit, G.
- Dunn Galvin, A.
- DunnGalvin, A.
- Durham, S.
- Eberlein, B.
- Ebisawa, M.
- Ebo, D.G.
- Eggel, A.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eigenmann, P.
- Eiwegger, T.
- Elenius, V.
- Eljaszewicz, A.
- Emeryk, A.
- Emson, C.
- Eyerich, K.
- Fakhimahmadi, A.
- Farkas, H.
- Fauquert, J.
- Favaro, A.
- Feketea, G.
- Feleszko, W.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Ferrando anaut, P.
- Fieten, K.B.
- Figueras Alsius, M.
- Fiocchi, A.
- Flokstra – de Blok, B.M.J.
- Florsheim, E.
- Fokkens, W.
- Fonseca, J.
- Forastiere, F.
- Freemantle, N.
- Fritzsching, B.
- Fu, W.
- Gainsborough, F.
- Galvan Blasco, P.
- Gamez, C.
- Gappa, M.
- Garvey, L.H.
- Gaudenzio, N.
- Gelincik, A.
- Geng, B.
- Gennery, A.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gervasoni, M.E.
- Gevaert, P.
- Gherasim, A.
- Giménez-Arnau, A.
- Giovannini, M.
- Gobert, D.
- Golding, M.
- Gomes, E.R.
- Gomes, J.
- Goncalo, M.
- Gonçalo, M.
- González Díaz, S.
- González germán, M.
- Goodman, R.
- Goossens, A.
- Gore, C.
- Grattan, C.
- Greenhawt, M.
- Grigg, J.
- Grimshaw, K.
- Gunawardana, N.
- Gupta, R.
- Gutermuth, J.
- Guttman-Yassky, E.
- Guttman, E.
- Hagemann, J.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heine, R.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Hilger, C.
- Hirahara, K.
- Hoffmann-Sommergruber, K.
- Holgate, S.
- Holmdahl, I.
- Holmes, S.
- Howarth, P.
- Huang, Y.
- Humbert, M.
- In't Veen, H.
- Izquierdo, E.
- Izuhara, K.
- Jackson, D.
- Jacobsen, L.
- Jakob, T.
- Janda, J.
- Jeebhay, M.
- Jeimy, S.
- Jensen-Jarolim, E.
- Jesenak, M.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Juskiene, I.
- Jutel, M.
- K Chu, D.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Kessel, A.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kiani-alikhan, S.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Korath, A.D.J.
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kucharczyk, A.
- Kuna, P.
- Kündig, T.
- Kupczyk, M.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Larenas-linnemann, D.
- Lau, S.
- Lauerma, A.
- Lee, Y.
- Leonardi, A.
- Levy, D.
- Liu, A.
- Lopata, A.
- Mack, D.
- Madrigal-Burgaleta, R.
- Magerl, M.
- Mahler, V.
- Mäkelä, M.
- Maleki, S.
- Malinovschi, A.
- Malmberg, P.L.
- Mantovani, A.
- Marcoux, D.
- Marrs, T.
- Marsella, R.
- Martins, C.
- Maspero, J.
- Mastalerz, L.
- Mathioudakis, A.
- Matricardi, P.
- Matucci, A.
- Maurer, M.
- Mayerhofer, H.
- Mayorga, C.
- McSorley, H.
- Melén, E.
- Menzies-Gow, A.
- Meyer, R.
- Michel, M.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Moya, B.
- Mueller, R.S.
- Mukherjee, M.
- Mullol, J.
- Muraro, A.
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Novak, N.
- Nutten, S.
- Nwaru, B.
- O'B Hourihane, J.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ogneva, D.
- Ollert, M.
- Ong, P.Y.
- Onorato, G.L.
- Pagani, M.
- Pali-Schöll, I.
- Paller, A.
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pascal, M.
- Pasmans, S.
- Pavlova, K.
- Pavord, I.
- Peden, D.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pfaller, B.
- Pietikäinen, S.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Porsbjerg, C.
- Portelli, M.
- Price, O.J.
- Prunicki, M.
- Qazi, K.
- Quirce, S.
- Rabe, K.F.
- Radzikowska, U.
- Recke, A.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Roberts, G.
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rodrigues-Cernadas, J.
- Rodríguez Del Río, P.
- Rondon, C.
- Rossi, A.
- Rostaher, A.
- Roth-Walter, F.
- Rothenberg, M.
- Rouger, M.
- Rovati, G.E.
- Rubin, E.
- Rudenko, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Sala Cunill, A.
- Salapatek, A.
- Sampson, H.
- Sandoval-Ruballos, M.
- Santos, A.
- Sastre, J.
- Satyaraj, E.
- Savic, S.
- Scadding, G.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schuijs, M.
- Schwarze, J.
- Sediva, A.
- Sekerel, B.
- Semernik, O.
- Serrano, C.
- Sevciovic Grumach, A.
- Shamji, M.H.
- Siebenhaar, F.
- Siegfried, E.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Solinski, M.
- Song, K.
- Sorensen, K.
- Spanevello, A.
- Spergel, J.
- Spolak-Bobryk, N.
- Spriggs, K.
- Stevens, W.
- Stobiecki, M.
- Stratton. R.
- Straumann, A.
- Sturm, G.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Szajewska, H.
- Szefler, S.
- Szymanski, L.
- Tan, B.
- Tanno, L.
- Tham, E.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Togias, A.
- Tomazic, P.
- Torrado español, I.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Ueki, S.
- Untersmayr, E.
- Vaia, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- Van Dijk, Y.
- van Neerven, R.
- van Ree, R.
- Van Schijndel, H.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Villaseñor solis, A.
- Vitte, J.
- Vlieg- Boerstra, B.
- Vogelberg, C.
- von Mutius, E.
- Vultaggio, A.
- Walsted, E.S.
- Walter, J.
- Wang, J.
- Wardzynska, A.
- Warner, A.
- Wechsler, M.
- Weidner, J.
- Weinberger, B.
- Werfel, T.
- Wiehn, E.
- Williams, S.
- Wong, C.
- Worm, M.
- Xepapadaki, V.
- Yepes-Nuñez, J.J.
- Yuste-Montalvo, A.
- Zednik, K.
- Zhang, L.
- Zieglmayer, P.
- Zissler, U.M.
- Zuberbier, T.

Article 03/11/2022

EAACI One Health 365

Read about this Article
Article 09/06/2022

Read here the latest ECDA statement on COVID-19, chronic diseases and EU Health Capacity

Read about this Article
Article 07/06/2022

European Parliament Interest Group on Allergy and Asthma

Read about this Article
Article 06/06/2022

The European Strategic Forum on Allergic Diseases

Read about this Article
Article 01/06/2022

EAACI Campaigns

Read about this Article

Public Outreach

What are you looking for?

EAACI One Health 365

Read here the latest ECDA statement on COVID-19, chronic diseases and EU Health Capacity

European Parliament Interest Group on Allergy and Asthma

The European Strategic Forum on Allergic Diseases

EAACI Campaigns